Palliative radiofrequency ablation for recurrent prostate cancer.
Percutaneous radiofrequency ablation (RFA) is a minimally invasive local therapy for cancer. Its efficacy is now becoming well documented in many different organs, including liver, kidney, and lung. The goal of RFA is typically complete eradication of a tumor in lieu of an invasive surgical procedure. However, RFA can also play an important role in the palliative care of cancer patients. Tumors which are surgically unresectable and incompatible for complete ablation present the opportunity for RFA to be used in a new paradigm. Cancer pain runs the gamut from minor discomfort relieved with mild pain medication to unrelenting suffering for the patient, poorly controlled by conventional means. RFA is a tool which can potentially palliate intractable cancer pain. We present here a case in which RFA provided pain relief in a patient with metastatic prostate cancer with pain uncontrolled by conventional methods.
Jindal
Gaurav
G
Diagnostic Radiology Department, National Institutes of Health, Bethesda, MD 20892, USA.
Friedman
Marc
M
Locklin
Julia
J
Wood
Bradford J
BJ
D000368:Aged; D017115:Catheter Ablation; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local; D010147:Pain Measurement; D010166:Palliative Care / Q000379:methods*; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery*; D014057:Tomography, X-Ray Computed